Nova Eye Medical Limited (ELXMF) Q4 2026 Earnings Call Transcript

SA Transcripts 161.45K Followers Follow Nova Eye Medical Limited ( ELXMF ) Q4 2026 Earnings Call August 3, 2026 9:30 PM EDT Company Participants Mark Flynn - Investor Relations Thomas Spurling - MD & Executive Director Presentation Mark Flynn Investor Relations Okay. Good morning, everybody, and thanks again for joining us. My name is Mark Flynn, Investor Relations for Nova Eye Medical. Today, we're covering the June '26 quarterly report, which we lodged last week with the ASX and also we'll provide some outlook on FY '27. Presenting, as always, today is Tom Spurling, our Managing Director. Again, Q&A is available. If you look inside Zoom Q&A function, we'll look to get to as many questions as possible. Also, we can follow up post the webinar, but I will ask a number of questions. So please place them in the Q&A function within Zoom. As we can see from the recent results, Tom led the company through a wonderful 4 consecutive years of sales growth above 25% and our FY '26 closed at just below USD 24 million, up 26% and the second half delivered the company's first positive EBITDA as guided by Tom and the team. So Tom will take you through these results, what drove it and also to provide some FY '27 guidance. So over to you, Tom. Thomas Spurling MD & Executive Director Thanks, Mark. I'm very pleased again to be speaking and talking to our company. It's another record attendance webinar. Having a lot of people interested in our company is very, I'll just say, heartwarming because it is. Now you see our opening slide. Just leave it up there -- sorry, Mark, just back, back, back. Our opening slide, I just want to say regular viewers will note that, that's quite a change in our slide formatting, and that's intentional. We hit some major milestones in this last half, and we are different. We are combining